Pharmacogenetics in Model-Based Optimization of Bevacizumab Therapy for Metastatic Colorectal Cancer

Vascular endothelial growth factor A (VEGF-A) and intercellular adhesion molecule 1 (ICAM-1) are significant regulators of angiogenesis, an important biological process involved in carcinogenesis. Bevacizumab, an anti-VEGF monoclonal antibody (MAB), is approved for the treatment of metastatic Colore...

Descripción completa

Detalles Bibliográficos
Autores principales: Papachristos, Apostolos, Karatza, Eleni, Kalofonos, Haralabos, Sivolapenko, Gregory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311957/
https://www.ncbi.nlm.nih.gov/pubmed/32466535
http://dx.doi.org/10.3390/ijms21113753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311957/
https://www.ncbi.nlm.nih.gov/pubmed/32466535
http://dx.doi.org/10.3390/ijms21113753

Ejemplares similares